SUPPLEMENTARY MATERIAL - Sustained hair regrowth with continued ritlecitinib treatment through Week 48 in patients with alopecia areata with or without early target responses: post hoc analysis of the ALLEGRO phase 2b/3 trial
收藏doi.org2025-03-22 收录
下载链接：
http://doi.org/10.17632/r34sk3mg2r.1
下载链接
链接失效反馈官方服务：
资源简介：
Supplemental Data, Plain Language Summary, and Video Abstract to accompany article: Piliang et al., Sustained hair regrowth with continued ritlecitinib treatment through Week 48 in patients with alopecia areata with or without early target responses: post hoc analysis of the ALLEGRO phase 2b/3 trial
伴随文章：《Piliang 等人，关于特应性皮炎患者接受利替昔尼治疗的持续发丝再生效果至第 48 周：ALLEGRO 阶段 2b/3 期临床试验的回顾性分析》的补充数据、平实语言摘要和视频摘要。
提供机构：
Mendeley Data
